Clinical Trials

Accrual Status
Limit to SWOG Trials

647 Results

Active Filters

Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer

Status Notes
This protocol will be permanently closed to accrual effective 10/1/15.
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Activated
05-15-2013
Closed
10-01-2015
ClinicalTrials.gov Registry Number
NCT01598298
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1115

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Research Committee(s)
Gastrointestinal Cancer
Activated
08-15-2012
Closed
05-15-2014
ClinicalTrials.gov Registry Number
NCT01658943
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III

Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Activated
02-01-2012
Closed
02-01-2013
ClinicalTrials.gov Registry Number
NCT01385137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination

Research Committee(s)
Prevention & Epidemiology
Activated
12-02-2011
Closed
08-05-2013
ClinicalTrials.gov Registry Number
NCT01512875
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

Research Committee(s)
Lymphoma
Activated
10-28-2011
Closed
06-06-2013